More articles from Brief Communication

You have access
Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb

Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
You have access
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel

Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Open Access
Evolution of ¹⁸F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
Andrew Thornton, Francesco Fraioli, Simon Wan, Helen S. Garthwaite, Balaji Ganeshan, Robert I. Shortman, Raymond Endozo, Stefan Vöö, Irfan Kayani, Deena Neriman, Leon Menezes, Jamshed Bomanji, Toby Hilllman, Melissa Heightman, Joanna C. Porter and Ashley M. Groves

Journal of Nuclear Medicine February 1, 2022, 63 (2) 270-273; DOI: https://doi.org/10.2967/jnumed.121.262296
You have access
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, Mark C. Markowski, Mei Xin, Michael A. Gorin, Baijun Dong, Jiahua Pan, Martin G. Pomper, Jianjun Liu, Kenneth J. Pienta, Wei Xue and Steven P. Rowe

Journal of Nuclear Medicine February 1, 2022, 63 (2) 248-252; DOI: https://doi.org/10.2967/jnumed.121.262411
You have access
⁶⁸Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms
Sabrina Kraus, Alexander Dierks, Leo Rasche, Olivia Kertels, Malte Kircher, Andreas Schirbel, Josip Zovko, Torsten Steinbrunn, Raoul Tibes, Hans-Jürgen Wester, Andreas K. Buck, Hermann Einsele, K. Martin Kortüm, Andreas Rosenwald and Constantin Lapa

Journal of Nuclear Medicine January 1, 2022, 63 (1) 96-99; DOI: https://doi.org/10.2967/jnumed.121.262206
Open Access
PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study
Justin Ferdinandus, Wolfgang P. Fendler, Andrea Farolfi, Samuel Washington, Osama Mohamad, Miguel H. Pampaloni, Peter J.H. Scott, Melissa Rodnick, Benjamin L. Viglianti, Matthias Eiber, Ken Herrmann, Johannes Czernin, Wesley R. Armstrong, Jeremie Calais, Thomas A. Hope and Morand Piert

Journal of Nuclear Medicine January 1, 2022, 63 (1) 76-80; DOI: https://doi.org/10.2967/jnumed.121.262821
Open Access
Use of ⁶⁴Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H Frankel, Mary Caroll, Yuan Yuan, Jinha Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Kofi Poku, John E Shively and David Colcher

Journal of Nuclear Medicine December 2, 2021, jnumed.121.262940; DOI: https://doi.org/10.2967/jnumed.121.262940
You have access
PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
Francesco Barbato, Wolfgang P. Fendler, Isabel Rauscher, Ken Herrmann, Axel Wetter, Justin Ferdinandus, Robert Seifert, Michael Nader, Kambiz Rahbar, Boris Hadaschik, Matthias Eiber, Andrei Gafita and Manuel Weber

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1747-1750; DOI: https://doi.org/10.2967/jnumed.121.262120
You have access
Prognostic Value of Bone Marrow Metabolism on Pretreatment ¹⁸F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru and Benjamin Lewis Franc

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1380-1383; DOI: https://doi.org/10.2967/jnumed.120.254482
You have access
First-in-Humans Application of ¹⁶¹Tb: A Feasibility Study Using ¹⁶¹Tb-DOTATOC
Richard P. Baum, Aviral Singh, Harshad R. Kulkarni, Peter Bernhardt, Tobias Rydén, Christiane Schuchardt, Nadezda Gracheva, Pascal V. Grundler, Ulli Köster, Dirk Müller, Michael Pröhl, Jan Rijn Zeevaart, Roger Schibli, Nicholas P. van der Meulen and Cristina Müller

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1391-1397; DOI: https://doi.org/10.2967/jnumed.120.258376

Main menu

User menu

Search

More articles from Brief Communication

Pages